Fenozolone
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:12, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 04:12, 22 June 2020 by DMacks (talk | contribs) (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB))
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.035.747 |
Chemical and physical data | |
Formula | C11H12N2O2 |
Molar mass | 204.229 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychostimulant related to pemoline.[2]
See also
References
- ^ DE 1297108, Beil W, Hoeppener A, Wolff HJ, "5-phenyl-2-ethylamino-4-oxazolinone and its preparation", issued 12 June 1969, assigned to Les Laboratoires Dausse SA
- ^ Gielsdorf W (February 1982). "Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography". Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie und Klinische Biochemie. 20 (2): 65–8. doi:10.1515/cclm.1982.20.2.65. PMID 6121837.
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |